Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:brand
gptkb:drug |
| gptkbp:activeIngredient |
gptkb:naloxone
|
| gptkbp:alternativeTo |
gptkb:Narcan
|
| gptkbp:approvalYear |
2014
|
| gptkbp:ATCCode |
V03AB15
|
| gptkbp:contains |
0.4 mg naloxone
2 mg naloxone |
| gptkbp:countryOfOperation |
gptkb:United_States
|
| gptkbp:form |
auto-injector
|
| https://www.w3.org/2000/01/rdf-schema#label |
Evzio
|
| gptkbp:indication |
opioid overdose
|
| gptkbp:legalStatus |
Rx-only
|
| gptkbp:manufacturer |
gptkb:Kaleo,_Inc.
|
| gptkbp:marketWithdrawal |
2020
|
| gptkbp:mechanismOfAction |
opioid
|
| gptkbp:pregnancyCategory |
C
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:retired |
commercial reasons
|
| gptkbp:routeOfAdministration |
intramuscular
subcutaneous |
| gptkbp:sideEffect |
nausea
vomiting hypertension tremor sweating seizures tachycardia |
| gptkbp:storage |
20-25°C
|
| gptkbp:usedFor |
emergency treatment
|
| gptkbp:bfsParent |
gptkb:Naloxone
|
| gptkbp:bfsLayer |
6
|